Very low temperature casting of controlled release microspheres

• US 5,019,400 A
• Filed: 05/01/1989
• Issued: 05/28/1991
• Est. Priority Date: 05/01/1989
• Status: Expired due to Term

• Current Assignee: Alkermes Controlled Therapeutics Inc. II (Alkermes plc)
• Original Assignee: Enzytech, Inc. (Alkermes plc)
• Inventors: Healy, Michael S., Brown, Larry R., Gombotz, Wayne R.
• Primary Examiner(s): Lovering, Richard D.
• Assistant Examiner(s): COVERT, JOHN
• Application Number:
  US07/346,143
• Time in Patent Office: 757 Days
• Field of Search: 427/213.36, 427/213.3, 427/212, 427/213.31, 427/213.32, 428/402.24, 424/489, 424/501, 424/502, 424/499, 424/490, 424/497, 264/13, 264/9, 264/28, 264/14
• US Class Current: 424/497
• CPC Class Codes: A61K 9/1694 resulting in granules or microspheres of the matrix type containing more than 5% of excipient
• CPC Class Codes: B29B 2009/125 Micropellets, microgranules, microparticles
• CPC Class Codes: B29B 9/10 by moulding the material, i.e. treating it in the molten state
• CPC Class Codes: F26B 3/12 in the form of a spray , i.e. sprayed or dispersed emulsions or suspensions spray drying of solutions B01D1/18
• CPC Class Codes: F26B 5/00 Drying solid materials or objects by processes not involving the application of heat separating liquids from solids by straining B01D; replacing liquids in wet solids by other liquids, e.g. water by spirit, B01D12/00; drying by electrophoresis B01J
• CPC Class Codes: F26B 7/00 Drying solid materials or objects by processes using a combination of processes not covered by a single one of groups F26B3/00 and F26B5/00 F26B1/005, F26B5/04, F26B23/026 take precedence
• CPC Class Codes: Y10T 428/2989 Microcapsule with solid core [includes liposome]

Abstract

A process for preparing microspheres using very cold temperatures to freeze polymer-biologically active agent mixtures into polymeric microspheres with very high retention of biological activity and material. Polymer is dissolved in a solvent together with an active agent that can be either dissolved in the solvent or dispersed in the solvent in the form of microparticles. The polymer/active agent mixture is atomized into a vessel containing a liquid non-solvent, alone or frozen and overlayed with a liquified gas, at a temperature below the freezing point of the polymer/active agent solution. The cold liquified gas or liquid immediately freezes the polymer droplets. As the droplets and non-solvent for the polymer is warmed, the solvent in the droplets thaws and is extracted into the non-solvent, resulting in hardened microspheres.

Claims

1. A method for preparing polymeric microspheres comprising

a) freezing droplets of polymer solution by atomizing the droplets into a liquified gas, having a temperature below the freezing point of the polymer solution effective to immediately freeze the atomized polymer solution upon contact, said liquified gas overlaying a layer of frozen liquid non-solvent for the polymer, wherein the polymer solvent is miscible in the liquid non-solvent;

b) thawing the polymer solvent in the frozen droplets of polymer solution; and

c) extracting the solvent from the droplets into a liquid non-solvent to form spherical polymeric microspheres.

2. The method of claim 1 further comprising:

evaporating the liquified gas after freezing the droplets of polymer solution; and

thawing the frozen liquid non-solvent to extract the solvent from the frozen droplets.

3. The method of claim 1 wherein the freezing non-solvent and the extracting non-solvent are the same.

4. The method of claim 1 further comprising providing a biologically active agent to be incorporated in the microspheres selected from the group consisting of proteins, short chain peptides, polysaccharides, nucleic acids, lipids, steroids, and organic and inorganic drugs.

5. The method of claim 1 wherein the liquified gas is selected from the group consisting of liquid argon (-185.6°

C.), liquid nitrogen (-195.8°

C.), and liquid oxygen (-182.9°

C.).

6. The method of claim 1 wherein the polymer is selected from the group consisting of poly(lactic acid), poly(lactic-co-glycolic acid), poly(caprolactone), polycarbonates, polyamides, polyanhydrides, polyamino acids, polyortho esters, polyacetals, polycyanoacrylates, polyurethanes, polyacrylates, ethylene-vinyl acetate and other acyl substituted cellulose acetates and derivatives thereof, polystyrenes, polyvinyl chloride, polyvinyl fluoride, poly(vinyl imidazole), chlorosulphonated polyolefins, polyethylene oxide, and copolymers and blends thereof.

7. The method of claim 1 further comprising removing the microspheres from the non-solvent.

8. The method of claim 1 wherein the polymer solution has a concentration between 1% and 20%.

9. The method of claim 1 wherein the microsphere has a final concentration of up to 50% by weight active non-polymeric components.

10. A porous polymeric microsphere having a diameter between 5 and 1000 microns, spherical in shape, not containing water in the polymer, formed by

a) freezing droplets of polymer solution by atomizing the droplets into a liquified gas, having a temperature below the freezing point of the polymer solution effective to immediately freeze the atomized polymer solution upon contact, said liquified gas overlaying a layer of frozen liquid non-solvent for the polymer, wherein the polymer solvent is miscible in the liquid non-solvent;

b) thawing the polymer solvent in the frozen polymeric droplets; and

c) extracting the solvent from the polymeric droplets into a liquid non-solvent to form spherical polymeric microspheres.

11. The microspheres of claim 10 wherein the polymer is selected from the group consisting of poly(lactic acid), poly(lactic-co-glycolic acid), poly(caprolactone), polycarbonates, polyamides, polyanhydrides, polyamino acids, polyortho esters, polyacetals, polycyanoacrylates, polyurethanes, polyacrylates, ethylene-vinyl acetate and other acyl substituted cellulose acetates and derivatives thereof, polystyrenes, polyvinyl chloride, polyvinyl fluoride, poly(vinyl imidazole), chlorosulphonated polyolefins, polyethylene oxide, and copolymers and blends thereof.

12. The microspheres of claim 10 further comprising a biologically active agent incorporated in the microspheres selected from the group consisting of proteins, short chain peptides, polysaccharides, nucleic acids, lipids, steroids, and organic and inorganic drugs, having greater than 90% of the biological activity of the agent before incorporation in the microspheres.

13. The microspheres of claim 12 further comprising a material selected from the group consisting of salts, metals, sugars, surface active agents, acids, bases, stabilizers, and release enhancing agents.

14. The microspheres of claim 12 wherein the polymer and agent form a heterogeneous mixture.

15. The microspheres of claim 12 wherein the polymer and agent form a homogeneous mixture.

16. The microspheres of claim 12 comprising a biologically active agent, wherein the agent after incorporation maintains greater than 90% of the biological activity present prior to incorporation into the microspheres, and said microspheres do not contain surface active agents.

17. The microspheres of claim 12 wherein the microsphere has a final concentration of up to 50% by weight non-polymeric components.

18. The microspheres of claim 12 wherein the microspheres have diameters of approximately 50 microns or less.